Загрузка...
The antimalarial ferroquine: from bench to clinic
Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falcip...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
EDP Sciences
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3671469/ https://ncbi.nlm.nih.gov/pubmed/21894260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1051/parasite/2011183207 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|